Date updated:08-06-2008
The traders looked at some trade ideas and options action in the biotech space.

-
BMY
Bristol-myers Squ - $24.46
- +1.79%
- $23.92
News of the Bristol-Meyers (BMY) offer to buy out ImClone (IMCL) deal triggered a flurry of option activity in Amgen (AMGN), Onyx Pharmaceuticals (ONXX), and Amylin (AMLN) said option strategist Frederic Ruffy.

-
IMCL
N/a - $69.67
- 0.00
- $69.67
News of the Bristol-Meyers (BMY) offer to buy out ImClone (IMCL) deal triggered a flurry of option activity in Amgen (AMGN), Onyx Pharmaceuticals (ONXX), and Amylin (AMLN) said option strategist Frederic Ruffy.

-
AMGN
Amgen Inc. - $55.38
- -1.21%
- $55.69
News of the Bristol-Meyers (BMY) offer to buy out ImClone (IMCL) deal triggered a flurry of option activity in Amgen (AMGN), Onyx Pharmaceuticals (ONXX), and Amylin (AMLN) said option strategist Frederic Ruffy.

-
ONXX
Onyx Pharmaceutic - $27.99
- +0.36%
- $27.83
News of the Bristol-Meyers (BMY) offer to buy out ImClone (IMCL) deal triggered a flurry of option activity in Amgen (AMGN), Onyx Pharmaceuticals (ONXX), and Amylin (AMLN) said option strategist Frederic Ruffy.

-
ONXX
Onyx Pharmaceutic - $27.99
- +0.36%
- $27.83
News of the Bristol-Meyers (BMY) offer to buy out ImClone (IMCL) deal triggered a flurry of option activity in Amgen (AMGN), Onyx Pharmaceuticals (ONXX), and Amylin (AMLN) said option strategist Frederic Ruffy.

-
AMLN
Amylin Pharmaceut - $12.44
- -2.58%
- $12.72
News of the Bristol-Meyers (BMY) offer to buy out ImClone (IMCL) deal triggered a flurry of option activity in Amgen (AMGN), Onyx Pharmaceuticals (ONXX), and Amylin (AMLN) said option strategist Frederic Ruffy.

-
BIIB
Biogen Idec Inc - $46.38
- +1.16%
- $45.56
I’m sniffing around Biogen (BIIB), says Karen Finerman. I think it was too beaten down.

-
CELG
Celgene Corporati - $54.91
- +0.66%
- $54.42
I still think the best play here IS Celgene (CELG) says Guy Adami. They could be a takeover target.
- Fast Money's Biotech Trades & Options Action's Blog
- No Blogs Found
- Top Professional Portfolios
- 1. Fidelity Contrafund - ...
- 2. Navellier & Associ...
- 3. Calamos Advisors
- 4. Argus Management
- 5. Bernard L. Madoff Inve...
- show all
- Top Do-It-Yourself Portfolios
- » Joseph Russell Portfolio 1
- » Albo's First Portfolio
- » Darrell Werth Portfolio 1
- » Echo5Joker's Portfolio
- » jgroov Portfolio 1
- show all
- Most Viewed Portfolios
- » Warren Buffett
- » George Soros
- » T. Boone Pickens - BP Cap...
- » Carl Icahn
- » Renaissance Technologies
- show all
By Jonas Elmerraji Posted on Nov. 23, 2009 As well as broad-based indexes have performed in the last few months, Stockpickr's weekly Rocket Stocks list has managed to d...
Not a Stockpickr member? Join the community today -- for free.Regardless of why a stock is in the news, it never hurts to hear what a professional investor has to say about...
By Roberto Pedone Posted on Nov. 20, 2009 According to Jim Cramer, options expiration is driving the current market selloff. He pointed out that the only stocks that we...
By Roberto Pedone Posted on Nov. 19, 2009 According to CNBC’s “Fast Money” traders, the stock market is showing no signs of stopping its current bull run. Joe Ter...
A. well, lets put it this way; i think gold
is headed for a top (dont konw how
major, but probably significant) and im
long
A. The only one I own : SLX,
too hard pick a winner out all of them
Here is the stock list of some of the largest % losers from Nov. 23, 2009. more
Here is a list of some of the biggest stocks that hit 52-week lows on Nov. 23, 2009. more
Here are some stocks that moved up on unusual volume on Nov. 23, 2009. more











Comments not available